Endocan as a predictor of increased cardiovascular risk during the menopausal transition period.
Yıldız, Şükrü
Endocan as a predictor of increased cardiovascular risk during the menopausal transition period. [electronic resource] - Archives of gynecology and obstetrics 06 2020 - 1553-1560 p. digital
Publication Type: Journal Article
1432-0711
10.1007/s00404-020-05520-7 doi
Cardiovascular Diseases--blood
Carotid Intima-Media Thickness
Cohort Studies
Cross-Sectional Studies
Female
Humans
Menopause--blood
Middle Aged
Neoplasm Proteins--blood
Premenopause--blood
Proteoglycans--blood
Risk Factors
Endocan as a predictor of increased cardiovascular risk during the menopausal transition period. [electronic resource] - Archives of gynecology and obstetrics 06 2020 - 1553-1560 p. digital
Publication Type: Journal Article
1432-0711
10.1007/s00404-020-05520-7 doi
Cardiovascular Diseases--blood
Carotid Intima-Media Thickness
Cohort Studies
Cross-Sectional Studies
Female
Humans
Menopause--blood
Middle Aged
Neoplasm Proteins--blood
Premenopause--blood
Proteoglycans--blood
Risk Factors